Verona Pharma plc Annual Net Cash Provided by (Used in) Financing Activities in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Verona Pharma plc quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2019 to 2023.
  • Verona Pharma plc Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was -$3.12M, a 105% decline year-over-year.
  • Verona Pharma plc annual Net Cash Provided by (Used in) Financing Activities for 2023 was $92.9M, a 34.1% decline from 2022.
  • Verona Pharma plc annual Net Cash Provided by (Used in) Financing Activities for 2022 was $141M.
  • Verona Pharma plc annual Net Cash Provided by (Used in) Financing Activities for 2021 was -$6.12M, a 103% decline from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $92.9M -$47.9M -34.1% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-29
2022 $141M +$147M Jan 1, 2022 Dec 31, 2022 10-K 2024-02-29
2021 -$6.12M -$198M -103% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-07
2020 $192M +$192M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-03
2019 $0 Jan 1, 2019 Dec 31, 2019 10-K 2021-02-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.